Eischen Christine M
Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA19107, USA.
J Mol Cell Biol. 2017 Feb 1;9(1):69-73. doi: 10.1093/jmcb/mjw052.
Mdm2 and Mdmx are critical regulators of the p53 tumour suppressor and are overexpressed in many human malignancies. However, in recent years, their impact on genome instability was shown to be at least, in part, independent of p53. Both Mdm2 and Mdmx inhibit DNA break repair through their association with the Mre11/Rad50/Nbs1 DNA repair complex. Recent evidence indicates that harnessing Mdm2 and/or Mdmx-mediated inhibition of DNA break repair in cancer cells could provide a therapeutic opportunity, particularly for those malignancies that have lost functional p53.
Mdm2和Mdmx是p53肿瘤抑制因子的关键调节因子,在许多人类恶性肿瘤中均有过表达。然而,近年来研究表明,它们对基因组不稳定的影响至少部分独立于p53。Mdm2和Mdmx均通过与Mre11/Rad50/Nbs1 DNA修复复合体结合来抑制DNA断裂修复。最近的证据表明,利用Mdm2和/或Mdmx介导的对癌细胞DNA断裂修复的抑制作用可能提供一种治疗机会,特别是对于那些已经失去功能性p53的恶性肿瘤。